News

Sales of Danish drugmaker Novo Nordisk 's Wegovy and U.S. rival Eli Lilly's Mounjaro in India doubled in July from a month ...
With skinny jabs and shrinking waistlines becoming the new normal‭, ‬many fitness conscious are opting for smaller‭, ...
AN influencer says she’s been trolled for still eating her favourite pizza, smothered in chips, cheese and curry sauce.
As Sky News research revealed thousands of severely obese patients are facing severely delayed treatment, here we look at the ...
The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...
Eli Lilly's weight-loss drug Mounjaro has achieved over Rs 100 crore in sales within four months of its launch in India.
Mr Ratcliffe started on Mounjaro after slowly regaining around 10 stone in weight following a successful Weight Watchers programme a decade before. It had become harder to lose weight as he got older, ...
Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...
A WOMAN who has lost 6st using weight loss jabs has warned against one of the hidden side effects. Kelly Kay, from the UK, ...
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...
People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.